Wikidata

(Q61915351)

English

Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity

clinical trial

In more languages

Statements

title
A Prospective Trial of Anti-TNF-Alpha Chimeric Monoclonal Antibody (Infliximab, Remicade®) on Insulin Sensitivity, Beta Cell Function and Cardiovascular Risk Profile in Insulin Resistant Human Obesity (English)
0 references
medical condition
obesity
0 references
country
Austria
0 references
start time
September 2005
0 references
end time
June 2007
0 references
number of participants
9
0 references
minimum age
20 year
0 references
maximum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61915351&oldid=2109973201"